Grupo Bimbo, S.A.B. de C.V. (GRBMF)
OTCMKTS · Delayed Price · Currency is USD
2.970
0.00 (0.00%)
Jul 31, 2025, 8:00 PM EDT
Verve Therapeutics Cash Flow Statement
Financials in millions MXN. Fiscal year is January - December.
Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 11,419 | 12,544 | 15,477 | 46,910 | 15,916 | 9,111 | Upgrade |
Depreciation & Amortization | 24,908 | 23,051 | 18,929 | 18,038 | 16,375 | 16,251 | Upgrade |
Loss (Gain) From Sale of Assets | 231.3 | -192 | 751 | 650 | 222 | -127 | Upgrade |
Asset Writedown & Restructuring Costs | 285.21 | 249 | 383 | 1,046 | 694 | 1,075 | Upgrade |
Loss (Gain) on Equity Investments | -415.12 | -464 | -316 | -452 | -247 | -194 | Upgrade |
Other Operating Activities | 25,008 | 25,152 | 23,849 | -9,201 | 17,513 | 20,834 | Upgrade |
Change in Accounts Receivable | -1,544 | -319 | -4,206 | -6,647 | 666 | -914 | Upgrade |
Change in Inventory | 121.55 | -1,104 | -1,078 | -4,163 | -2,320 | -769 | Upgrade |
Change in Accounts Payable | 301.52 | -2,672 | -1,023 | 10,207 | 8,495 | 3,274 | Upgrade |
Change in Income Taxes | -6,472 | -6,472 | -13,831 | -11,824 | -7,578 | -5,789 | Upgrade |
Change in Other Net Operating Assets | -8,373 | -9,866 | -7,501 | -6,556 | -5,459 | -212 | Upgrade |
Operating Cash Flow | 45,469 | 39,907 | 31,411 | 38,851 | 45,776 | 43,877 | Upgrade |
Operating Cash Flow Growth | 17.97% | 27.05% | -19.15% | -15.13% | 4.33% | 53.85% | Upgrade |
Capital Expenditures | -27,017 | -29,402 | -34,754 | -28,669 | -20,671 | -13,218 | Upgrade |
Sale of Property, Plant & Equipment | 861.35 | 984 | 152 | 20 | 882 | 763 | Upgrade |
Cash Acquisitions | -9,456 | -5,988 | -6,548 | -6,520 | -10,637 | -3,453 | Upgrade |
Sale (Purchase) of Intangibles | -1,288 | -1,477 | -1,047 | -795 | -699 | -879 | Upgrade |
Investment in Securities | -1,795 | -1,841 | -561 | -127 | -534 | -163 | Upgrade |
Other Investing Activities | 1,720 | 1,586 | 318 | 26,969 | -800 | 262 | Upgrade |
Investing Cash Flow | -36,975 | -36,138 | -42,440 | -9,122 | -32,459 | -16,688 | Upgrade |
Long-Term Debt Issued | - | 79,111 | 136,638 | 51,670 | 38,924 | 34,818 | Upgrade |
Long-Term Debt Repaid | - | -63,567 | -116,125 | -61,927 | -38,907 | -46,289 | Upgrade |
Net Debt Issued (Repaid) | 10,055 | 15,544 | 20,513 | -10,257 | 17 | -11,471 | Upgrade |
Repurchase of Common Stock | -2,789 | -4,433 | -3,664 | -2,912 | -1,901 | -3,740 | Upgrade |
Common Dividends Paid | -4,342 | -4,125 | -3,458 | -5,791 | -4,636 | -2,433 | Upgrade |
Other Financing Activities | -11,541 | -9,682 | -7,487 | -6,732 | -7,596 | -6,519 | Upgrade |
Financing Cash Flow | -8,618 | -2,696 | 5,904 | -25,692 | -14,116 | -24,163 | Upgrade |
Foreign Exchange Rate Adjustments | 1.97 | 631 | -835 | -472 | 279 | -9 | Upgrade |
Net Cash Flow | -121.77 | 1,704 | -5,960 | 3,565 | -520 | 3,017 | Upgrade |
Free Cash Flow | 18,452 | 10,505 | -3,343 | 10,182 | 25,105 | 30,659 | Upgrade |
Free Cash Flow Growth | 327.69% | - | - | -59.44% | -18.12% | 99.05% | Upgrade |
Free Cash Flow Margin | 4.32% | 2.57% | -0.84% | 2.55% | 7.41% | 9.49% | Upgrade |
Free Cash Flow Per Share | 4.47 | 2.41 | -0.76 | 2.29 | 5.59 | 6.73 | Upgrade |
Cash Interest Paid | 10,235 | 8,376 | 7,436 | 6,407 | 6,781 | 6,410 | Upgrade |
Cash Income Tax Paid | 7,769 | 6,472 | 13,831 | 11,824 | 7,578 | 5,789 | Upgrade |
Levered Free Cash Flow | 13,831 | 7,820 | -9,183 | 14,298 | 16,568 | 23,441 | Upgrade |
Unlevered Free Cash Flow | 22,209 | 15,813 | -3,186 | 18,747 | 21,211 | 28,968 | Upgrade |
Change in Net Working Capital | -1,223 | 1,017 | 11,165 | -6,533 | -5,502 | -7,617 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.